FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model

Cardiovascular Research

Volumn 91, Issue 4, 2011, Pages 587-597

  Schips, Tobias G ^a   Wietelmann, Astrid ^b   Höhn, Katharina ^a   Schimanski, Silvia ^b   Walther, Paul ^a   Braun, Thomas ^b   Wirth, Thomas ^a   Maier, Harald J ^a  

^a UNIVERSITY OF ULM   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Autophagy; Cardiac atrophy; FoxO; Mitochondria; Transgenic mice

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MOLECULAR MARKER; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; NATRIURETIC FACTOR; PROTEIN BNIP3; TETRACYCLINE; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CELL DEATH; HEART DISEASE; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART OUTPUT; HEART SIZE; HEART STROKE VOLUME; HEART WEIGHT; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SARCOMERE; SIGNAL TRANSDUCTION;

ANIMALS; ATROPHY; AUTOPHAGY; BODY WEIGHT; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SIZE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VENTRICULAR REMODELING;

EID: 80051970950     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr144     Document Type: Article

References (34)

1. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008;358:1370-1380.
2. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002;109:629-639. (Pubitemid 34204842)
3. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 2000;19: 2537-2548. (Pubitemid 30323543)
4. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93:215-228. (Pubitemid 28180855)
5. Shiojima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 2006;20:3347-3365. (Pubitemid 44969154)
6. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96: 857-868. (Pubitemid 29165088)
7. Calnan DR, Brunet A. The FoxO code. Oncogene 2008;27:2276-2288. (Pubitemid 351501779)
8. Hannenhalli S, Putt ME, Gilmore JM,Wang J, Parmacek MS, Epstein JA et al. Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation 2006;114:1269-1276. (Pubitemid 44402052)
9. Evans-Anderson HJ, Alfieri CM, Yutzey KE. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Circ Res 2008;102:686-694. (Pubitemid 351457856)
10. Wong A, Woodcock EA. FoxO proteins and cardiac pathology. Adv Exp Med Biol 2009;665:78-89.
11. Ronnebaum SM, Patterson C. The FoxO family in cardiac function and dysfunction. Annu Rev Physiol 2010;72:81-94.
12. Ni YG, Berenji K, Wang N, Oh M, Sachan N, Dey A et al. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 2006;114: 1159-1168. (Pubitemid 44386480)
13. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004;117:399-412. (Pubitemid 38534545)
14. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007;6:472-483. (Pubitemid 350163056)
15. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007;6:458-471. (Pubitemid 350163055)
16. Skurk C, Izumiya Y, Maatz H, Razeghi P, Shiojima I, Sandri M et al. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem 2005;280:20814-20823. (Pubitemid 40776786)
17. Sengupta A, Molkentin JD, Yutzey KE. FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem 2009;284:28319-28331.
18. Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, Lam EW et al. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 2002;22:7842-7852. (Pubitemid 35217295)
19. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992;89:5547-5551.
20. Passman RS, Fishman GI. Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest 1994;94:2421-2425. (Pubitemid 24379617)
21. Larson AC, White RD, Laub G, McVeigh ER, Li D, Simonetti OP. Self-gated cardiac cine MRI. Magn Reson Med 2004;51:93-102. (Pubitemid 38095706)
22. Wessells RJ, Fitzgerald E, Cypser JR, Tatar M, Bodmer R. Insulin regulation of heart function in aging fruit flies. Nat Genet 2004;36:1275-1281. (Pubitemid 39577935)
23. Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ Jr, DiStefano PS et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 2002;296:530-534. (Pubitemid 34408672)
24. Lee JH, Budanov AV, Park EJ, Birse R, Kim TE, Perkins GA et al. Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science 2010;327:1223-1228.
25. Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, Litwin SE. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 2003;285:H1261-H1269. (Pubitemid 37048185)
26. Gottlieb RA, Mentzer RM. Autophagy during cardiac stress: joys and frustrations of autophagy. Annu Rev Physiol 2010;72:45-59.
27. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T et al. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 2009;461:654-658.
28. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirshenbaum LA et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 2007;14:146-157. (Pubitemid 44911902)
29. Romanello V, Guadagnin E, Gomes L, Roder I, Sandri C, Petersen Y et al. Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J 2010;29: 1774-1785.
30. Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest 2007;117:2825-2833. (Pubitemid 47529613)
31. Diwan A, Wansapura J, Syed FM, Matkovich SJ, Lorenz JN, Dorn GW 2nd). Nixmediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation. Circulation 2008;117:396-404.
32. Ni YG, Wang N, Cao DJ, Sachan N, Morris DJ, Gerard RD et al. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci USA 2007;104:20517-20522.
33. Razeghi P, Sharma S, Ying J, Li YP, Stepkowski S, Reid MB et al. Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation 2003;108:2536-2541. (Pubitemid 37444418)
34. Chen Y, Park S, Li Y, Missov E, Hou M, Han X et al. Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 2003;14:251-260. (Pubitemid 37345233)